Free Trial

Adverum Biotechnologies (ADVM) SEC Filings & 10K Form

Adverum Biotechnologies logo
$3.26 +0.03 (+0.93%)
As of 04:00 PM Eastern

Recent Adverum Biotechnologies SEC Filings

DateFilerForm TypeView
04/28/2025
2:24 PM
Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
2:31 PM
Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Form 4/A
04/24/2025
8:35 AM
Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2025
6:30 AM
Adverum Biotechnologies (Filer)
Form PRE 14A
04/15/2025
6:30 AM
Adverum Biotechnologies (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/15/2025
6:43 AM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2025
5:07 PM
Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2025
6:06 PM
Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
7:02 PM
Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:04 PM
Adverum Biotechnologies (Issuer)
Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Leonard Braden Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:59 PM
Adverum Biotechnologies (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/14/2025
5:10 PM
Adverum Biotechnologies (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SCHEDULE 13G/A
02/13/2025
2:25 PM
Adverum Biotechnologies (Subject)
BML Investment Partners, L.P. (Filed by)
Form SCHEDULE 13G/A
12/19/2024
3:14 PM
Adverum Biotechnologies (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/17/2024
4:11 PM
Adverum Biotechnologies (Subject)
Rush Ryan Bradford (Filed by)
Form SCHEDULE 13G
11/14/2024
5:40 PM
Adverum Biotechnologies (Subject)
Logos Global Management LP (Filed by)
Form SC 13G/A
11/14/2024
5:57 PM
Adverum Biotechnologies (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
Form SC 13G/A
11/06/2024
4:49 PM
Adverum Biotechnologies (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G/A
11/04/2024
3:42 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
3:44 PM
Adverum Biotechnologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
11:41 AM
Adverum Biotechnologies (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SCHEDULE 13G
10/30/2024
8:34 PM
Adverum Biotechnologies (Subject)
Stern Augustus (Filed by)
Form SC 13G
10/23/2024
12:34 PM
Adverum Biotechnologies (Subject)
Principia Wealth Advisory, LLC (Filed by)
Form SC 13G
10/22/2024
5:06 PM
Adverum Biotechnologies (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
08/12/2024
3:08 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
3:10 PM
Adverum Biotechnologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/22/2024
3:24 PM
Adverum Biotechnologies (Subject)
BML Investment Partners, L.P. (Filed by)
Form SC 13G/A
07/18/2024
8:16 PM
Adverum Biotechnologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
8:16 PM
Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Leonard Braden Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
8:16 PM
Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Leonard Braden Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/17/2024
3:38 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
3:47 PM
Adverum Biotechnologies (Issuer)
Svoronos Dawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:48 PM
Adverum Biotechnologies (Issuer)
Lupher, Jr. Mark L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:48 PM
Adverum Biotechnologies (Issuer)
Hong Soo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:49 PM
Adverum Biotechnologies (Issuer)
Nicholson, C. David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:50 PM
Adverum Biotechnologies (Issuer)
Ozden Rabia Gurses (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:42 PM
Adverum Biotechnologies (Issuer)
Kiss Szilard (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/20/2024
3:43 PM
Adverum Biotechnologies (Issuer)
Kiss Szilard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:43 PM
Adverum Biotechnologies (Issuer)
Machado Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:44 PM
Adverum Biotechnologies (Issuer)
Scopa James Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:45 PM
Adverum Biotechnologies (Issuer)
Whitcup Scott M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Elon Reveals Why There Soon Won’t Be Any Money For Social Security (Ad)

Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.

See why thousands of forward-thinking retirement savers are now requesting this FREE 2025 Wealth Pro
06/20/2024
3:46 PM
Adverum Biotechnologies (Issuer)
Tuckson Reed Vaughn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:10 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ADVM) was last updated on 4/30/2025 by MarketBeat.com Staff
From Our Partners